The analysis of a rocket tomography measurement of the N2+3914A emission and N2 ionization rates in an auroral arc

Techniques were developed for recovering two-dimensional distributions of auroral volume emission rates from rocket photometer measurements made in a tomographic spin scan mode. These tomographic inversion procedures are based upon an algebraic reconstruction technique (ART) and utilize two different iterative relaxation techniques for solving the problems associated with noise in the observational data. One of the inversion algorithms is based upon a least squares method and the other on a maximum probability approach. The performance of the inversion algorithms, and the limitations of the rocket tomography technique, were critically assessed using various factors such as (1) statistical and non-statistical noise in the observational data, (2) rocket penetration of the auroral form, (3) background sources of emission, (4) smearing due to the photometer field of view, and (5) temporal variations in the auroral form. These tests show that the inversion procedures may be successfully applied to rocket observations made in medium intensity aurora with standard rocket photometer instruments. The inversion procedures have been used to recover two-dimensional distributions of auroral emission rates and ionization rates from an existing set of N2+3914A rocket photometer measurements which were made in a tomographic spin scan mode during the ARIES auroral campaign. The two-dimensional distributions of the 3914A volume emission rates recoverd from the inversion of the rocket data compare very well with the distributions that were inferred from ground-based measurements using triangulation-tomography techniques and the N2 ionization rates derived from the rocket tomography results are in very good agreement with the in situ particle measurements that were made during the flight. Three pre-prints describing the tomographic inversion techniques and the tomographic analysis of the ARIES rocket data are included as appendices

The altitude dependence of the OH(X2[Pi]) vibrational distribution in the nightglow: Some model expectations

A number of different OH Meinel band excitation models are used to investigate the extent to which quenching and vibrational deactivation processes could cause the nightglow OH vibrational distributions to vary with altitude. The various models, which are based upon those described by McDade and Llewellyn (1988, Planet. Space Sci. 36, 897), are used to calculate the steady state OH vibrational distributions throughout the 80-100 km region. The results of the calculation show that, irrespective of the basic model assumptions, the OH vibrational distributions should not be strongly altitude dependent and that the emission profiles of the Meinel bands from the [upsi]' levels 1 through 9 should not differ in altitude by more than one or two kilometers. The results of some recent laboratory studies pertaining to the Meinel band excitation mechanism are also discussed and it is shown that stepwise collisional vibrational deactivation is unlikely to play a major role in controlling the observed nightglow OH vibrational distribution.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/29270/1/0000329.pd

A rocket tomography measurement of the N+2 3914 A emission rates within an auroral arc

A rocket tomography experiment designed to measure the two-dimensional distribution of the N+2 3914 A volume emission rates within an auroral arc is described. A simple filter photometer on board a sounding rocket, which was launched during the ARIES auroral campaign, was used to measure the 3914 A auroral brightnesses at elevation angles ranging from 0[deg] to 360[deg] in the plane of the rocket trajectory. The measured auroral brightnesses have been tomographically inverted to recover the local 3914 A volume emission rates as a function of both altitude and latitude within the arc. The tomographic inversion procedure, which is based upon a maximum probability algebraic reconstruction approach, is described and the implications of the results for studies of auroral excitation processes are briefly discussed.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/29317/1/0000382.pd

Gallin; an antimicrobial peptide member of a new avian defensin family, the ovodefensins, has been subject to recent gene duplication

Background: Egg white must provide nutrients and protection to the developing avian embryo. One way in which this is achieved is an arsenal of antimicrobial proteins and peptides which are essentially extensions of the innate immune system. Gallin is a recently identified member of a family of peptides that are found in egg white. The function of this peptide family has not been identified and they are potentially antimicrobial. Results: We have confirmed that there are at least 3 forms of the gallin gene in the chicken genome in 3 separate lines of chicken, all the forms are expressed in the tubular cells of the magnum region of the oviduct, consistent with its presence in egg white. mRNA expression levels are in the order 10,000 times greater in the magnum than the shell gland. The conservation between the multiple forms of gallin in the chicken genome compared with the conservation between gallin and other avian gallin like peptides, suggests that the gene duplication has occurred relatively recently in the chicken lineage. The gallin peptide family contains a six cysteine motif (C-X-5-C-X-3-C-X-11-CX3-C-C) found in all defensins, and is most closely related to avian beta-defensins, although the cysteine spacing differs. Further support for the classification comes from the presence of a glycine at position 10 in the 41 amino acid peptide. Recombinant gallin inhibited the growth of Escherischia coli (E. coli) at a concentration of 0.25 mu M confirming it as part of the antimicrobial innate immune system in avian species. Conclusions: The relatively recent evolution of multiple forms of a member of a new defensin related group of peptides that we have termed ovodefensins, may be an adaptation to increase expression or the first steps in divergent evolution of the gene in chickens. The potent antimicrobial activity of the peptide against E. coli increases our understanding of the antimicrobial strategies of the avian innate immune system particularly those of the egg white and the evolution of the defensin family. The potential of this peptide and others in the family can now be investigated in a number of novel antimicrobial role

TIMED Imaging Photometer Experiment (TIPE)

This document contains a summary of the TIMED Imaging Photometer Experiment (TIPE) instrument study at the time of the termination of project due to TIPE being de-selected from the Thermosphere, Ionosphere and Mesosphere Energetics and Dynamics (TIMED) mission

The aries auroral modelling campaign: characterization and modelling of an evening auroral arc observed from a rocket and a ground-based line of meridian scanners

An auroral arc system excited by soft electrons was studied with a combination of in situ rocket measurements and optical tomographic techniques, using data from a photometer on a horizontal, spinning rocket and a line of three meridian scanning photometers. The ground-based scanner data at 4709, 5577, 8446 and 6300 A were successfully inverted to provide a set of volume emission rate distributions in the plane of the rocket trajectory, with a basic time resolution of 24 s. Volume emission rate profiles, derived from these distributions peaked at about 150 km for 5577 and 4709 A, while the 8446 A emission peaked at about 170 km with a more extended height distribution. The rocket photometer gave comparable volume emission rate distributions for the 3914 A emission as reported in a separate paper by McDade et al. (1991, Planet. Space Sci. 39, 895). Instruments on the rocket measured the primary electron flux during the flight and, in particular, the flux precipitating into the auroral arc overflown at apogee (McEwen et al., 1991; in preparation). The local electron density and temperature were measured by probes on the rocket (Margot and McNamara (1991; Can. J. Phys. 69, 950). The electron density measurements on the downleg were modelled using ion production rate data derived from the optical results. Model calculations of the emission height profile based on the measured electron flux agree with the observed profiles. The height distribution of the N2+ emission in the equatorward band, through which the rocket passed during the descent, was measured by both the rocket and the ground-based tomographic techniques and the results are in good agreement. Comparison of these profiles with model profiles indicates that the exciting primary spectrum may be represented by an accelerated Maxwellian or a Gaussian distribution centered at about 3 keV. This distribution is close to what would be obtained if the electron flux exciting the poleward form were accelerated by a 1-2 kV upward potential drop. The relative height profiles for the volume emission rate of the 5577 A OI emission and the 4709 A N2+ emission were almost indistinguishable from each other for both the forms measured, with ratios in the range 38-50; this is equivalent to I(5577)/I(4278) ratios of 8-10. The auroral intensities and intensity ratios measured in the magnetic zenith from the ground during the period before and during the rocket flight are consistent with the primary electron fluxes and height distributions measured from the rocket. Values of I(5577)/I(4278) in the range 8-10 were also measured directly by the zenith ground photometers over which the arc system passed. These values are slightly higher than those reported by Gattinger and Vallance-Jones (1972) and this may possibly indicate an enhancement of the atomic oxygen concentration at the time of the flight. Such an enhancement would be consistent with our result, that the observed values of I(5577) and I(8446) are also significantly higher than those modelled on the basis of the electron flux spectrum measured at apogee.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/29020/1/0000050.pd

Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism.

BACKGROUND: The use of levothyroxine to treat subclinical hypothyroidism is controversial. We aimed to determine whether levothyroxine provided clinical benefits in older persons with this condition. METHODS: We conducted a double-blind, randomized, placebo-controlled, parallel-group trial involving 737 adults who were at least 65 years of age and who had persisting subclinical hypothyroidism (thyrotropin level, 4.60 to 19.99 mIU per liter; free thyroxine level within the reference range). A total of 368 patients were assigned to receive levothyroxine (at a starting dose of 50 μg daily, or 25 μg if the body weight was <50 kg or the patient had coronary heart disease), with dose adjustment according to the thyrotropin level; 369 patients were assigned to receive placebo with mock dose adjustment. The two primary outcomes were the change in the Hypothyroid Symptoms score and Tiredness score on a thyroid-related quality-of-life questionnaire at 1 year (range of each scale is 0 to 100, with higher scores indicating more symptoms or tiredness, respectively; minimum clinically important difference, 9 points). RESULTS: The mean age of the patients was 74.4 years, and 396 patients (53.7%) were women. The mean (±SD) thyrotropin level was 6.40±2.01 mIU per liter at baseline; at 1 year, this level had decreased to 5.48 mIU per liter in the placebo group, as compared with 3.63 mIU per liter in the levothyroxine group (P<0.001), at a median dose of 50 μg. We found no differences in the mean change at 1 year in the Hypothyroid Symptoms score (0.2±15.3 in the placebo group and 0.2±14.4 in the levothyroxine group; between-group difference, 0.0; 95% confidence interval [CI], -2.0 to 2.1) or the Tiredness score (3.2±17.7 and 3.8±18.4, respectively; between-group difference, 0.4; 95% CI, -2.1 to 2.9). No beneficial effects of levothyroxine were seen on secondary-outcome measures. There was no significant excess of serious adverse events prespecified as being of special interest. CONCLUSIONS: Levothyroxine provided no apparent benefits in older persons with subclinical hypothyroidism. (Funded by European Union FP7 and others; TRUST ClinicalTrials.gov number, NCT01660126 .)

Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study.

INTRODUCTION: Identifying at what point atrophy rates first change in Alzheimer's disease is important for informing design of presymptomatic trials. METHODS: Serial T1-weighted magnetic resonance imaging scans of 94 participants (28 noncarriers, 66 carriers) from the Dominantly Inherited Alzheimer Network were used to measure brain, ventricular, and hippocampal atrophy rates. For each structure, nonlinear mixed-effects models estimated the change-points when atrophy rates deviate from normal and the rates of change before and after this point. RESULTS: Atrophy increased after the change-point, which occurred 1-1.5 years (assuming a single step change in atrophy rate) or 3-8 years (assuming gradual acceleration of atrophy) before expected symptom onset. At expected symptom onset, estimated atrophy rates were at least 3.6 times than those before the change-point. DISCUSSION: Atrophy rates are pathologically increased up to seven years before "expected onset". During this period, atrophy rates may be useful for inclusion and tracking of disease progression

Comment on “Middle atmosphere heating by exothermic chemical reactions involving odd‐hydrogen species”

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/95675/1/grl5702.pd